Deltagen, Inc.
Records under this name other than patents Deltagen, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,661,138 | Vibration Generating Motor Lapsed on the fee record Ended Dec 9, 2015 · High confidence | Lapsed on the fee record | Ended Dec 9, 2015 | High confidence |
| US 6,942,995 | Methods of creating constructs useful for introducing sequences into embryonic stem cells Lapsed on the fee record Ended Sep 13, 2013 · From the USPTO record | Lapsed on the fee record | Ended Sep 13, 2013 | From the USPTO record |
| US 7,176,346 | SLC19A2 amino acid transporter gene disruptions, and compositions and methods related thereto Lapsed on the fee record Ended Feb 13, 2011 · From the USPTO record | Lapsed on the fee record | Ended Feb 13, 2011 | From the USPTO record |
| US 7,164,055 | HSPC150-like gene disruptions, compositions and methods related thereto Lapsed on the fee record Ended Jan 16, 2011 · From the USPTO record | Lapsed on the fee record | Ended Jan 16, 2011 | From the USPTO record |
| US 7,030,291 | CYT28 serpentine receptor disruptions, compositions and methods relating thereto Lapsed on the fee record Ended Apr 18, 2010 · From the USPTO record | Lapsed on the fee record | Ended Apr 18, 2010 | From the USPTO record |
| US 6,943,277 | Transgenic mice containing stefin homolog protease inhibitor gene disruptions Lapsed on the fee record Ended Sep 13, 2009 · From the USPTO record | Lapsed on the fee record | Ended Sep 13, 2009 | From the USPTO record |
| US 6,929,909 | Gene targeting vectors comprising conditional positive selection markers Lapsed on the fee record Ended Aug 16, 2009 · From the USPTO record | Lapsed on the fee record | Ended Aug 16, 2009 | From the USPTO record |
| US 6,909,031 | Transgenic mice containing glucagon receptor gene disruptions Lapsed on the fee record Ended Jun 21, 2009 · From the USPTO record | Lapsed on the fee record | Ended Jun 21, 2009 | From the USPTO record |
| US 6,858,772 | Transgenic mice containing magnesium-dependent protein phosphatase gene disruptions Lapsed on the fee record Ended Feb 22, 2009 · From the USPTO record | Lapsed on the fee record | Ended Feb 22, 2009 | From the USPTO record |
| US 6,784,335 | Transgenic mice containing BMP gene disruptions Lapsed on the fee record Ended Aug 31, 2008 · From the USPTO record | Lapsed on the fee record | Ended Aug 31, 2008 | From the USPTO record |